Viewing Study NCT01012102


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-01-10 @ 4:54 PM
Study NCT ID: NCT01012102
Status: COMPLETED
Last Update Posted: 2014-02-20
First Post: 2009-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EMD 640744 View
None Montanide View
None Advanced solid tumours View